Cargando…

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients

BACKGROUND: Heparin administration in COVID-19 patients is recommended by expert consensus, although evidence about dosage, duration and efficacy are limited. We aim to investigate the association between different dosages of low molecular weight heparin (LMWH) and mortality among COVID-19 hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paolisso, Pasquale, Bergamaschi, Luca, D’Angelo, Emanuela Concetta, Donati, Francesco, Giannella, Maddalena, Tedeschi, Sara, Pascale, Renato, Bartoletti, Michele, Tesini, Giulia, Biffi, Mauro, Cosmi, Benilde, Pizzi, Carmine, Viale, Pierluigi, Galié, Nazzareno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424043/ https://www.ncbi.nlm.nih.gov/pubmed/32848743 http://dx.doi.org/10.3389/fphar.2020.01124

Ejemplares similares

The value of ECG changes in risk stratification of COVID‐19 patients
por: Bergamaschi, Luca, et al.
Publicado: (2021)

Opportunistic infections in end stage liver disease
por: Bartoletti, Michele, et al.
Publicado: (2018)

Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease
por: Paolisso, Pasquale, et al.
Publicado: (2020)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Subacute pericardial abscess after aortic valve replacement: a case report
por: Magnani, Ilenia, et al.
Publicado: (2020)

Heparin-induced thrombocytopenia and COVID-19
por: Sartori, Michelangelo, et al.
Publicado: (2021)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020)

Genetics and clinical phenotype of Erdheim–Chester disease: A case report of constrictive pericarditis and a systematic review of the literature
por: Bartoli, Lorenzo, et al.
Publicado: (2022)

Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
por: Marfella, R., et al.
Publicado: (2020)

Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA
por: Paolisso, Pasquale, et al.
Publicado: (2021)

Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA
por: Paolisso, Pasquale, et al.
Publicado: (2021)

Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study
por: Pascale, Renato, et al.
Publicado: (2021)

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections
por: Giannella, Maddalena, et al.
Publicado: (2019)

Klebsiella pneumoniae Bloodstream Infection: Epidemiology and Impact of Inappropriate Empirical Therapy
por: Girometti, Nicolò, et al.
Publicado: (2014)

Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study
por: Giannella, Maddalena, et al.
Publicado: (2022)

Response of the Authors
por: Bergamaschi, Luca, et al.
Publicado: (2021)

Primary malignant pericardial tumour in Lynch syndrome
por: Paolisso, Pasquale, et al.
Publicado: (2020)

A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis
por: Gatti, Milo, et al.
Publicado: (2022)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018
por: Gaibani, Paolo, et al.
Publicado: (2021)

Impact on Mortality of a Bundle for the Management of Enterococcal Bloodstream Infection
por: Bartoletti, Michele, et al.
Publicado: (2019)

Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Sex-Related Disparities in Cardiac Masses: Clinical Features and Outcomes
por: Angeli, Francesco, et al.
Publicado: (2023)

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
por: Gatti, Milo, et al.
Publicado: (2021)

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study
por: Cesaro, Arturo, et al.
Publicado: (2022)

Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
por: Paolisso, Pasquale, et al.
Publicado: (2023)

Reply to SGLT-2 inhibitors: Post-infarction interventional effects
por: Paolisso, Pasquale, et al.
Publicado: (2023)

Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study
por: Rinaldi, Matteo, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia
por: Gatti, Milo, et al.
Publicado: (2022)

Effective Containment of a COVID-19 Subregional Outbreak in Italy Through Strict Quarantine and Rearrangement of Local Health Care Services
por: Tedeschi, Sara, et al.
Publicado: (2021)

147. Non-Fermenting Gram-Negative Bloodstream Infection: A Multicenter Retrospective Cohort Study
por: Pascale, Renato, et al.
Publicado: (2019)

Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients
por: Gatti, Milo, et al.
Publicado: (2022)

The Gut Microbiota of Critically Ill Patients With COVID-19
por: Gaibani, Paolo, et al.
Publicado: (2021)

Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: a case series
por: Bartoletti, Michele, et al.
Publicado: (2014)

Oral Versus Standard Antimicrobial Treatment for Pyogenic Native Vertebral Osteomyelitis: A Single-Center, Retrospective, Propensity Score-Balanced Analysis
por: Marconi, Lorenzo, et al.
Publicado: (2022)

The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review
por: Gozzo, Lucia, et al.
Publicado: (2020)

Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study
por: Bartoletti, Michele, et al.
Publicado: (2021)

How much European prescribing physicians know about invasive fungal infections management?
por: Valerio, Maricela, et al.
Publicado: (2015)

Beyond the World Symposium on Pulmonary Hypertension: practical management of pulmonary arterial hypertension and evolving concepts
por: Vachiéry, Jean-Luc, et al.
Publicado: (2019)

New horizons in pulmonary arterial hypertension therapies
por: Galiè, Nazzareno, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nk0ap5a52p9k2844v8eb0u5o8g